In a significant stride towards sustainable IT solutions, Hewlett Packard Enterprise (HPE) has partnered with Astellas Pharma Inc., marking a pivotal initiative in the global pharmaceutical sector’s approach to environmental stewardship and technological innovation. This collaboration is centered around the deployment of HPE Asset Upcycling Services across various Astellas locations, beginning with Canada. This initiative stands as a testament to both organizations’ commitment to sustainability, aiming to set a benchmark in the pharmaceutical industry for responsible technology management and environmental conservation.

The deal between HPE and Astellas Pharma Inc. leverages HPE’s Asset Upcycling Services to collect and process end-of-use network equipment, aiding Astellas’ network standardization project. This service not only underscores the companies’ dedication to modernizing IT infrastructure but also highlights their commitment to reducing environmental impact. The first collection of networking assets in Canada marks the inception of this venture, with plans to extend the service to Astellas’ headquarters in Japan, targeting the decommissioning and secure refurbishment of hundreds of technology assets annually.

Astellas Pharma Inc., a global leader in the pharmaceutical industry, aims to bolster its sustainability efforts through this initiative, receiving annual HPE Circular Economy Reports that detail the reuse versus recycle rate of decommissioned products. This endeavor aligns with Astellas’ corporate social responsibility goals, driving progress towards carbon neutrality.

HPE Asset Upcycling Services emerge as a crucial element in Astellas’ strategy to modernize its IT estate while fostering a circular economy. The service is lauded for its consistent quality in securely processing and refurbishing a wide array of end-of-use hardware, including network assets, storage, servers, and various workplace devices. Yasunori Yakabe, Astellas’ Director and Head of Cloud Products and Platforms, emphasized the dual focus on IT modernization and environmental impact mitigation, highlighting the role of HPE Asset Upcycling Services in achieving these objectives.

Furthermore, Astellas has integrated HPE Aruba Networking solutions to enhance its backbone network infrastructure. This move is pivotal for supporting the company’s expansive operations, which span research, development, and manufacturing of innovative medicines. HPE Aruba Networking Central will provide Astellas with advanced capabilities, including AI-powered analytics, automation, and enhanced security features, facilitating centralized management and improved IT productivity.

Hirokazu Mochizuki, Senior Vice President and Managing Director for HPE Japan, expressed honor in supporting Astellas’ sustainability and networking enhancement goals. Mochizuki highlighted the benefits of HPE Aruba Networking Central in addressing legacy networking challenges and enhancing user experience, underscoring the significance of the HPE Circular Economy Report in tracking environmental impact reductions.

This partnership not only exemplifies a robust approach to sustainable IT management in the pharmaceutical industry but also serves as a model for other sectors striving for environmental stewardship through technological innovation.

  Astellas Pharma Inc., carbon neutrality in pharmaceuticals, Circular Economy, corporate social responsibility, environmental sustainability in the pharmaceutical industry, Hewlett Packard Enterprise, HPE Aruba Networking solutions, HPE Asset Upcycling Services, network standardization, sustainable IT solutions, technology refurbishment